Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
3.380
-0.060 (-1.74%)
Jul 21, 2025, 2:47 PM - Market open

Anixa Biosciences Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
108.87M

Revenue Chart

Created with Highcharts 11.4.8Anixa Biosciences Revenue - Annual512.00K512.00K210.00K210.00K20202021202220232024-100K200K300K400K500K

Revenue History

Fiscal Year EndRevenueChangeGrowth
Oct 31, 2024---
Oct 31, 2023210.00K--
Oct 31, 2022---
Oct 31, 2021512.00K--
Oct 31, 2020---
Oct 31, 2019 Pro Pro Pro
Oct 31, 2018 Pro Pro Pro
Oct 31, 2017 Pro Pro Pro
Oct 31, 2016 Pro Pro Pro
Oct 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson90.63B
Merck & Co.63.92B
AbbVie57.37B
Novartis AG55.19B
AstraZeneca54.98B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings